NDC 15631-0507
ALFALFA
Alfalfa
ALFALFA is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Alfalfa.
| Product ID | 15631-0507_e47dac17-ea46-46ed-b3ae-75cd921afe6e |
| NDC | 15631-0507 |
| Product Type | Human Otc Drug |
| Proprietary Name | ALFALFA |
| Generic Name | Alfalfa |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-12-30 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| Substance Name | ALFALFA |
| Active Ingredient Strength | 1 [hp_X]/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 15631-0507-7
10000 TABLET in 1 CONTAINER (15631-0507-7)
| Marketing Start Date | 2015-12-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 15631-0507-0 [15631050700]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-6 [15631050706]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-3 [15631050703]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-4 [15631050704]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-7 [15631050707]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-1 [15631050701]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-5 [15631050705]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
NDC 15631-0507-2 [15631050702]
ALFALFA TABLET
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2015-12-30 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ALFALFA | 1 [hp_X]/1 |
OpenFDA Data
| SPL SET ID: | 05ed31c4-fb2e-4ca4-bf2e-171b9a4f0b18 |
| Manufacturer | |
| UNII | |
| UPC Code |
NDC Crossover Matching brand name "ALFALFA" or generic name "Alfalfa"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0220-0161 | Alfalfa | ALFALFA |
| 0220-0164 | Alfalfa | ALFALFA |
| 15631-0014 | ALFALFA | ALFALFA |
| 15631-0507 | ALFALFA | ALFALFA |
| 22840-1507 | Alfalfa | Medicago sativa |
| 22840-1508 | Alfalfa | Medicago sativa |
| 22840-1509 | Alfalfa | Medicago sativa |
| 22840-1561 | Alfalfa | Medicago sativa |
| 22840-5503 | Alfalfa | Medicago sativa |
| 60512-6469 | ALFALFA | ALFALFA |
| 68428-872 | Alfalfa | ALFALFA |
| 71919-027 | Alfalfa | ALFALFA |
| 0268-1012 | MEDICAGO SATIVA POLLEN | Alfalfa |
| 0268-1013 | MEDICAGO SATIVA POLLEN | Alfalfa |
| 0268-6602 | MEDICAGO SATIVA POLLEN | Alfalfa |
Trademark Results [ALFALFA]
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.